Hirokazu Okada
Papers
1
Total Citations
41
H-Index
1
About
Dr. Hirokazu Okada is a leading nephrologist whose research centers on the molecular mechanisms of kidney disease, particularly the roles of the renin-angiotensin system (RAS) in glomerulonephritis and diabetic nephropathy. His most-cited work, "A Possible Anti-Inflammatory Role of Angiotensin II Type 2 Receptor in Immune-Mediated Glomerulonephritis during Type 1 Receptor Blockade" (2006, 41 citations), provides critical insight into how blocking the angiotensin II type 1 receptor (AT1R) can unmask protective, anti-inflammatory effects mediated by the type 2 receptor (AT2R) in immune-driven kidney injury. This finding has important implications for designing more targeted therapies that leverage AT2R activation to reduce inflammation without compromising blood pressure control. Beyond this landmark study, Dr. Okada has contributed extensively to understanding how RAS blockade influences renal fibrosis, podocyte injury, and tubular damage. His work bridges basic immunology and clinical nephrology, offering translational pathways for treating chronic kidney disease. With a career spanning over two decades, Dr. Okada’s research continues to shape how clinicians and scientists approach the complex interplay between the immune system and the RAS in kidney pathology.
Research Focus
Key Achievements
Top Papers
- 1